Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Non-Current Assets (2018 - 2025)

TELA Bio has reported Non-Current Assets over the past 8 years, most recently at $5.8 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $5.8 million for Q4 2025, down 31.32% from a year ago — trailing twelve months through Dec 2025 was $25.7 million (down 28.08% YoY), and the annual figure for FY2025 was $5.8 million, down 31.32%.
  • Non-Current Assets for Q4 2025 was $5.8 million at TELA Bio, up from $5.5 million in the prior quarter.
  • Over the last five years, Non-Current Assets for TELA hit a ceiling of $9.2 million in Q1 2024 and a floor of $3.1 million in Q2 2021.
  • Median Non-Current Assets over the past 5 years was $5.6 million (2022), compared with a mean of $5.9 million.
  • Biggest five-year swings in Non-Current Assets: soared 86.0% in 2022 and later crashed 37.65% in 2025.
  • TELA Bio's Non-Current Assets stood at $3.5 million in 2021, then skyrocketed by 55.0% to $5.4 million in 2022, then increased by 16.9% to $6.3 million in 2023, then soared by 34.44% to $8.5 million in 2024, then plummeted by 31.32% to $5.8 million in 2025.
  • The last three reported values for Non-Current Assets were $5.8 million (Q4 2025), $5.5 million (Q3 2025), and $6.8 million (Q2 2025) per Business Quant data.